M2 TAMs promote tumor progression by expressing PD-L1, remodeling the extracellular matrix through matrix metalloproteinases (MMP2, MMP9), enhancing angiogenesis via vascular endothelial growth factor (VEGF), and recruiting immunosuppressive cells such as Tregs. This evidence concerns the gene MMP9 and neoplasm.